Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Finasteride blocks progesterone's effect on absence seizures in rats.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Southeast Asian herbs show promise for skin and hair care, but more research is needed to confirm their effectiveness in cosmetics.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Alcohol in teen years leads to more adult drinking, finasteride doesn't help.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Allopregnanolone increases KCC2 expression in baby male rats' brains, while finasteride doesn't affect it.

Ketoconazole shampoo is a safe and effective treatment for scalp seborrheic dermatitis.